Investment Success in Public Health: An Analysis of the Cost-Effectiveness and Cost-Benefit of the Global Programme to Eliminate Lymphatic Filariasis

BACKGROUND. It has been estimated that $154 million per year will be required during 2015–2020 to continue the Global Programme to Eliminate Lymphatic Filariasis (GPELF). In light of this, it is important to understand the program’s current value. Here, we evaluate the cost-effectiveness and cost-be...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Clin Infect Dis
Egile Nagusiak: Turner, Hugo C., Bettis, Alison A., Chu, Brian K., McFarland, Deborah A., Hooper, Pamela J., Mante, Sunny D., Fitzpatrick, Christopher, Bradley, Mark H.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2017
Gaiak:
Major Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5404931/
https://ncbi.nlm.nih.gov/pubmed/27956460
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciw835
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak